+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

JCR Pharmaceuticals Co Ltd (4552) - Financial and Strategic SWOT Analysis Review

JCR Pharmaceuticals Co Ltd (4552) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports, and exports pharmaceutical products, regenerative drugs and drug substances. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, Turner syndrome, adult growth hormone deficiency, small for gestational age, renal anemia in dialysis patients, and anemia of prematurity; and a regenerative medical product for acute graft-versus-host disease and other disorders. JCR is also involved in the purchasing, selling, import and export of medical devices and laboratory instruments. It operates subsidiaries in Japan, Brazil, Switzerland and the US. JCR is headquartered in Ashiya, Hyogo, Japan.

JCR Pharmaceuticals Co Ltd Key Recent Developments

  • May 12, 2023: Angelini Pharma and JCR partner to develop new therapies for epilepsy
  • Jan 31, 2023: JCR Pharmaceuticals Announces Financial Summary Consolidated Financial Results for the Nine Months ended December 31, 2022
  • Oct 26, 2022: JCR Pharmaceuticals announces Financial Summary Consolidated Financial Results for the Six Months ended September 30, 2022 (FY2022) (Japanese standard)
  • Feb 15, 2022: JCR Pharmaceuticals' research presentations at WORLDSymposium 2022 showcase JR-141 (Pabinafusp Alfa) and other investigational treatments for lysosomal storage disorders

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • JCR Pharmaceuticals Co Ltd - Key Facts
  • JCR Pharmaceuticals Co Ltd - Key Employees
  • JCR Pharmaceuticals Co Ltd - Major Products and Services
  • JCR Pharmaceuticals Co Ltd - History
  • JCR Pharmaceuticals Co Ltd - Company Statement
  • JCR Pharmaceuticals Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
Section 2 - Company Analysis
  • Company Overview
  • JCR Pharmaceuticals Co Ltd - Business Description
  • Product Category: Agalsidase Beta BS I.V. Infusion [JCR]
  • Performance
  • Product Category: AZD1222 Bulk Solution
  • Performance
  • Product Category: Darbepoetin Alpha BS Inj.[JCR]
  • Performance
  • Product Category: Epoetin Alpha BS Inj.[JCR]
  • Performance
  • Product Category: Growject
  • Performance
  • Product Category: Income from Contractual Payment
  • Performance
  • Product Category: IZCARGO for I.V. Infusion
  • Performance
  • Product Category: Medical Devices
  • Performance
  • Product Category: Others
  • Performance
  • Product Category: TEMCELL HS Inj
  • Performance
  • R&D Overview
  • JCR Pharmaceuticals Co Ltd - Corporate Strategy
  • JCR Pharmaceuticals Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • JCR Pharmaceuticals Co Ltd - Strengths
  • JCR Pharmaceuticals Co Ltd - Weaknesses
  • JCR Pharmaceuticals Co Ltd - Opportunities
  • JCR Pharmaceuticals Co Ltd - Threats
  • JCR Pharmaceuticals Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • JCR Pharmaceuticals Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 12, 2023: Angelini Pharma and JCR partner to develop new therapies for epilepsy
  • Jan 31, 2023: JCR Pharmaceuticals Announces Financial Summary Consolidated Financial Results for the Nine Months ended December 31, 2022
  • Oct 26, 2022: JCR Pharmaceuticals announces Financial Summary Consolidated Financial Results for the Six Months ended September 30, 2022 (FY2022) (Japanese standard)
  • Feb 15, 2022: JCR Pharmaceuticals’ research presentations at WORLDSymposium 2022 showcase JR-141 (Pabinafusp Alfa) and other investigational treatments for lysosomal storage disorders
  • Feb 03, 2022: JCR Pharmaceuticals to Present at the 18 th Annual WORLDSymposium 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • JCR Pharmaceuticals Co Ltd, Key Facts
  • JCR Pharmaceuticals Co Ltd, Key Employees
  • JCR Pharmaceuticals Co Ltd, Major Products and Services
  • JCR Pharmaceuticals Co Ltd, History
  • JCR Pharmaceuticals Co Ltd, Other Locations
  • JCR Pharmaceuticals Co Ltd, Subsidiaries
  • JCR Pharmaceuticals Co Ltd, Affiliate
  • JCR Pharmaceuticals Co Ltd, Key Competitors
  • JCR Pharmaceuticals Co Ltd, Ratios based on current share price
  • JCR Pharmaceuticals Co Ltd, Annual Ratios
  • JCR Pharmaceuticals Co Ltd, Interim Ratios
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • JCR Pharmaceuticals Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • JCR Pharmaceuticals Co Ltd, Performance Chart (2019 - 2023)
  • JCR Pharmaceuticals Co Ltd, Ratio Charts
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Zeria Pharmaceutical Co Ltd
  • Sinphar Pharmaceutical Co Ltd
  • Kobayashi Pharmaceutical Co Ltd
  • OrphanPacific Inc
  • StemRIM Inc
  • Shaanxi Jiali Pharmaceuticals Co Ltd
  • Nissan Chemical Corp
  • Takeda Pharmaceutical Co Ltd
  • Nissan Chemical Corp
  • StemRIM Inc
  • Shaanxi Jiali Pharmaceuticals Co Ltd
  • Kobayashi Pharmaceutical Co Ltd
  • OrphanPacific Inc
  • Takeda Pharmaceutical Co Ltd
  • Zeria Pharmaceutical Co Ltd
  • Sinphar Pharmaceutical Co Ltd